| Product NDC: | 55390-413 |
| Proprietary Name: | Haloperidol decanoate |
| Non Proprietary Name: | Haloperidol decanoate |
| Active Ingredient(s): | 141.04 mg/mL & nbsp; Haloperidol decanoate |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-413 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075305 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19981001 |
| Package NDC: | 55390-413-05 |
| Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-413-05) > 5 mL in 1 VIAL |
| NDC Code | 55390-413-05 |
| Proprietary Name | Haloperidol decanoate |
| Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-413-05) > 5 mL in 1 VIAL |
| Product NDC | 55390-413 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Haloperidol decanoate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19981001 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | HALOPERIDOL DECANOATE |
| Strength Number | 141.04 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |